Does Egrifta (tesamorelin) have a US patent still in force?
Egrifta (tesamorelin) is protected in the US by patents and regulatory exclusivities that can limit generic and biosimilar competition. Exact “still in force” status depends on the specific patent(s) listed for the drug and the current expiration/terminal date for each one, which is not provided in the question here.
Which US patents cover Egrifta and when do they expire?
US coverage for a prescription product like Egrifta typically comes from:
- One or more formulation, composition-of-matter, or method-of-use patents, each with its own expiration date, and
- Potential additional protection tied to regulatory exclusivity (which can differ from patent expiry).
To answer precisely, you’d need to check the Orange Book listing for Egrifta (tesamorelin) and review the “patent expires” dates for each listed US patent.
How do I check Egrifta’s US patent expiration dates (fast)?
The most reliable public source is the FDA’s Drug Price Competition data (Orange Book). You can:
1. Search for “Egrifta” or “tesamorelin” on the Orange Book,
2. Open the product listing, and
3. Look at the listed patents and their “expires” dates.
If you tell me the exact product strength/package you mean (e.g., Egrifta vs Egrifta SV) and whether you want the latest Orange Book listing, I can help interpret what the listed expiration dates mean for generic entry.
Will generics be allowed as soon as the last patent expires?
Not necessarily. Even after patent expiry, approval timing for generics can be affected by:
- Other still-active patents listed in the Orange Book,
- Any regulatory exclusivities, and
- Patent “suit” and litigation timelines under the Hatch-Waxman framework (for Abbreviated New Drug Applications).
Is Egrifta SV different from Egrifta for patent purposes?
Often the active ingredient is the same but the protected product presentation (device, dosing regimen, formulation, or method claims) can change the patent landscape. That’s why you need to use the specific Orange Book product entry corresponding to “Egrifta SV.”
What I need from you to give a concrete expiration answer
Send either:
- A link or the exact Orange Book entry for “Egrifta SV,” or
- The patent numbers shown in the Orange Book listing,
and I’ll map each one to its US expiration date and explain what that means for generic competition.